Stocks and Investing Stocks and Investing
Tue, August 8, 2023
Mon, August 7, 2023

Patrick Trucchio Maintained (VIR) at Strong Buy with Decreased Target to $95 on, Aug 7th, 2023


Published on 2024-10-28 05:35:55 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $100 to $95 on, Aug 7th, 2023.

Patrick has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michelle Gilson of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, July 21st, 2023


These are the ratings of the 3 analyists that currently disagree with Patrick


  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Friday, August 4th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Friday, July 21st, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, July 21st, 2023